Hepatotoxicity
Showing 1 - 25 of 718
Pharmacogenomics of Asparaginase Induced Hepatotoxicity
Suspended
- Acute Lymphoblastic Leukemia
- Biospecimen Collection
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Nov 18, 2022
Cancer Trial in Changsha (Protein Kinase Inhibitor)
Recruiting
- Cancer
- Protein Kinase Inhibitor
-
Changsha, Hunan, ChinaCentral South University
Jun 23, 2022
Acute Lymphoblastic Leukemia, Hepatotoxicity Trial in Orange (Levocarnitine)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- Hepatotoxicity
-
Orange, California
- +1 more
Aug 12, 2022
Hepatotoxicity, Tenosynovial Giant Cell Tumor Trial in United States (TURALIO™)
Recruiting
- Hepatotoxicity
- Tenosynovial Giant Cell Tumor
-
Santa Monica, California
- +4 more
Jun 6, 2022
Leukemia, Myeloid, Acute Trial in Pierre-Bénite (Posaconazole)
Recruiting
- Leukemia, Myeloid, Acute
-
Pierre-Bénite, FranceCentre Hospitalier Lyon Sud, Hematology department
Feb 23, 2022
B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Lymphoblastic Lymphoma Trial
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- +5 more
- Biospecimen Collection
- +4 more
- (no location specified)
Oct 28, 2022
Hepatotoxicity in Rheumatoid Arthritis Through Pharmacokinetic
Completed
- Rheumatoid Arthritis
- Leflunomide 20Mg Tab
-
Assiut, EgyptAssiut University Hospital
Sep 6, 2020
Chemical and Drug Induced Liver Injury Trial (None intervetion)
Unknown status
- Chemical and Drug Induced Liver Injury
- None intervetion
- (no location specified)
Nov 7, 2019
Tuberculosis, Pulmonary Trial (Optimised dose rifampicin, Standard dose rifampicin)
Not yet recruiting
- Tuberculosis, Pulmonary
- Optimised dose rifampicin
- Standard dose rifampicin
- (no location specified)
Sep 26, 2023
PRJ2203: Dolutegravir Post Authorization Safety Study (PASS)
Completed
- Infection, Human Immunodeficiency Virus I
- DTG based ARV regimen with ABC
- +4 more
- (no location specified)
Feb 5, 2020
Monitoring the HePAtological TOXicity of Drugs (HePATOX)
Unknown status
- Liver Diseases
- +3 more
- Drugs inducing hepatological toxicity
-
Paris, FranceAP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, C
Sep 2, 2019
Remaxol® in Drug-induced Liver Injuries During Antitumor Therapy
Recruiting
- Cancer
- Drug Induced Liver Injury
-
Krasnoyarsk, Russian Federation
- +4 more
Mar 16, 2023
Pain, Fever, Hepatotoxicity Trial in Boston (Acetaminophen)
Completed
- Pain
- +2 more
-
Boston, MassachusettsTufts Clinical Pharmacology Study Unit
May 9, 2019
Aplastic Anemia Trial in Beijing (Ciclosporin, Avatrombopag, Anti-Human Thymocyte Immunoglobulin, Rabbit)
Not yet recruiting
- Aplastic Anemia
- Ciclosporin
- +2 more
-
Beijing, ChinaPeking union medical college hospital
Aug 16, 2023
Breast Cancer Trial in Hangzhou (Docetaxel, Carboplatin, Trastuzumab)
Recruiting
- Breast Cancer
- Docetaxel
- +6 more
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 28, 2022
Epilepsy, Lamotrigine, Sodium Valproate Adverse Reaction Trial (Sodium Valproate 500 Mg Prolonged-Release Oral Tablet,
Not yet recruiting
- Epilepsy
- +2 more
- Sodium Valproate 500 Mg Prolonged-Release Oral Tablet
- +2 more
- (no location specified)
May 20, 2023
Liver Cancer Trial in Kansas City (Stereotactic Body Radiation Treatment)
Not yet recruiting
- Liver Cancer
- Stereotactic Body Radiation Treatment
-
Kansas City, KansasUniversity of Kansas Medical Center
Feb 13, 2023
BrazilianDiagnosis of Spinal Muscular Atrophy Treated With
Not yet recruiting
- Spinal Muscular Atrophies
- Onasemnogene Abeparvovec
- (no location specified)
Aug 25, 2023
Cirrhosis Trial in United States (Placebo Oral Tablet, Simvastatin 40mg)
Recruiting
- Cirrhosis
- Placebo Oral Tablet
- Simvastatin 40mg
-
San Francisco, California
- +11 more
Jun 16, 2022
Colorectal Cancer, Peritoneal Metastases Trial in Eindhoven, Rotterdam (Irinotecan, FOLFOX regimen, Bevacizumab)
Recruiting
- Colorectal Cancer
- Peritoneal Metastases
- Irinotecan
- +2 more
-
Eindhoven, Netherlands
- +1 more
Aug 15, 2023
Complicated Staphylococcus Aureus (S. Aureus) Infections (CSAI) Trial in Basel (FLU or CZO as continuous infusion, standard FLU
Not yet recruiting
- Complicated Staphylococcus Aureus (S. Aureus) Infections (CSAI)
- FLU or CZO as continuous infusion
- standard FLU or CZO intermittent bolus administration
-
Basel, SwitzerlandUniversity Hospital Basel, Division of Internal Medicine
Dec 14, 2022
Advanced Pancreatic Cancer and Cholangiocarcinoma Trial in Hangzhou (PRRT with 177Lu-EB-FAPI)
Recruiting
- Advanced Pancreatic Cancer and Cholangiocarcinoma
- PRRT with 177Lu-EB-FAPI
-
Hangzhou, Zhejiang, ChinaFirst Affiliated Hospital of Zhejiang University
Oct 10, 2023
Breast Cancer, Peripheral Neuropathy, Cardiac Toxicities Trial in Tanta (Silymarin, Placebo)
Enrolling by invitation
- Breast Cancer
- +4 more
- Silymarin
- Placebo
-
Tanta, EgyptTanta university
Oct 22, 2022